SIRT3 and chronic hepatitis: The findings suggest that these agents, as SIRT3 modulators, can be used in preventing or treating oxidative injury to hepatocytes caused by major pathogenesis of various chronic liver diseases, ethanol cellular injury, and chronic hepatitis.